Platelet function studies in myeloproliferative disorders.

G. Pfliegler, Z. Boda, M. Udvardy, A. Kiss, B. Telek, K. Pecze, P. Nagy, K. Rak

Research output: Contribution to journalArticle

3 Citations (Scopus)


Platelet functions were studied in 64 patients with various myeloproliferative diseases. The characteristic alterations were prolonged bleeding time, decreased platelet aggregation (but normal results induced by ristomycin), elevated level of BTG, high production of MDA, increased level of TXB2 with almost normal level of 6-keto-PGF1. However, considering the bleeding time and the amount of BTG in relation to the whole blood platelet count, no differences could be detected.

Original languageEnglish
Pages (from-to)655-662
Number of pages8
JournalFolia haematologica : internationales Magazin fur klinische und morphologische Blutforschung
Issue number5
Publication statusPublished - Dec 1 1986

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'Platelet function studies in myeloproliferative disorders.'. Together they form a unique fingerprint.

  • Cite this